Trial Profile
Phase II/III study of MBP-426 in pancreatic cancer patients
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 04 Nov 2016
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 04 Nov 2016 New trial record